Wuhan Hiteck Biological Pharma Co Ltd (300683.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE1000034C5
Wuhan Hiteck Biological Pharma Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 648.97 m CNY | 541.45 m CNY |
| Gross profit | 268.09 m CNY | 230.88 m CNY |
| Operating income | -75.71 m CNY | -121.77 m CNY |
| EBIT | -77.13 m CNY | -237.37 m CNY |
| Net income | -69.35 m CNY | -231.27 m CNY |
| Diluted EPS – continuing operations | -0.53 CNY | -1.77 CNY |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Wuhan Hiteck Biological Pharma Co Ltd
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the production and sales of bioengineering products and lyophilized powder injections in China and internationally. The company operates through Biopharmaceutical Division; Pharmaceutical Technology Services Division; In Vitro Diagnostic Reagents Division; Production and Sales Division of Active Pharmaceutical Ingredients and Pharmaceutical Intermediates; and Other Divisions segments. Its products include Epramine for injection; mouse nerve growth factor for injection; omeprazole sodium for injection, an alternative therapy for duodenal ulcer, gastric ulcer, reflux esophagitis; tinidazole suppository, acyclovir dispersible tablets, nimodipine extended-release tablets, trimetazidine hydrochloride tablets, azithromycin granules, esomeprazole sodium for injection, and cyclic adenosine monophosphate for injection; Pentoxone theobromine injection; Roxatidine Acetate Hydrochloride for Injection; and Terizazole phosphate for injection. The company also provides measles and rubella virus nucleic acid detection kits; isolation and identification tubes and kits for mycoplasma; and bacterial vaginosis (BV) rapid test kits, as well as diagnostic kits for novel coronavirus N-Protein, as well as raw materials and intermediates. In addition, it offers diagnostic kits for IgG antibody to measles virus, hydatid, toxoplasma, rubella virus, cytomegalo virus, and herpes simplex virus I/II; diagnostic kits for IgM antibody to measles virus, herpes simplex virus I/II, cytomegalo virus, rubella virus, and toxoplasma; and diagnostic kits for a "Thalassemia. Further, the company provides Lopinavir and Ritonavir APIs, and intermediates. It offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co.,Ltd was founded in 1992 and is based in Wuhan, China.
More stocks
- Kaufman Et Broad (KOF.PA)
- PRA GROUP INC (PRAA)
- Philoptics Co., Ltd. (161580.KQ)
- Stemmer Imaging (S9I.HM)
- Hvm, Co.,Ltd. (295310.KQ)
- Pioneer Bancorp, Inc./MD (PBFS)
- STARZ ENTERTAINMENT CORP /CN/ (STRZ)
- indie Semiconductor, Inc. (INDI)
- Siamgas and Petrochemicals Public Company Limited (SGP.BK)
- Dongwon System (014820.KS)
- Lutian Machinery Co Ltd (605259.SS)
- Shenzhen TVT Digital Technology Co Ltd (002835.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.